Status:
COMPLETED
The Effect of Lumify™ Eyedrops on Eyelid Position
Lead Sponsor:
University of Miami
Conditions:
Eyelid Droop
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the research is to see if Lumify™ has an effect on eyelid position.
Eligibility Criteria
Inclusion
- Adults age 18 and above able to provide informed consent to participate
- Subject with stable ocular health, defined as no ocular conditions requiring ongoing topical therapy or recent surgical intervention
Exclusion
- Adults unable to consent
- Prisoners
- Pregnant women.
- Known contradictions or sensitivities to study medication (brimonidine)
- Ocular surgery within the past 3 months or refractive surgery within the past six months
- Grossly abnormal lid margins, anatomical abnormalities, previous eyelid or orbital surgery
- Variable ptosis or eyelid position (e.g., myasthenia gravis, thyroid eye disease, or blepharospasm)
- Significant pre-existing ptosis of any cause (defined as margin reflex distance 1 \< 1mm)
- Any ocular or systemic condition that, in the opinion of the investigator, would confound study data, interfere with the subject's study participation, or affected the subject's safety or trial parameters
- Presence of an active ocular infection
- Prior (within 5 days of beginning study treatment) use of eye whiteners (eg, vasoconstrictors), decongestants, antihistamines (including over the counter and herbal topical ophthalmic medications), phenylephrine dilating drops, any other topical ophthalmic agents
- Inability to sit comfortably for 15 - 30 minutes
Key Trial Info
Start Date :
June 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03782701
Start Date
June 18 2019
End Date
April 1 2020
Last Update
June 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bascom Palmer Eye Institute
Miami, Florida, United States, 33136